US Patent 7425547 Nucleoside derivatives for treating hepatitis C virus infection

Patent 7425547 was granted and assigned to Genelabs Technologies on September, 2008 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Genelabs Technologies

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

74255470

Patent Inventor Names

Natalia B. Dyatkina0

Christopher Don Roberts0

Date of Patent

September 16, 2008

Patent Application Number

106769560

Date Filed

September 30, 2003

Patent Primary Examiner

‌

L. E. Crane, Esq.

Patent abstract

Disclosed are compounds, compositions and methods for treating viral infections caused by a flaviviridae family virus, such as hepatitis C virus. Such compounds are represented by Formula IB as follows:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7425547 Nucleoside derivatives for treating hepatitis C virus infection

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API